1 / 6

Centre for Research Ethics & Bioethics

This initiative by Uppsala University and the Swedish University of Agricultural Sciences explores the advancements in diagnostics, emphasizing early phase diagnosis through new biomarkers for conditions like heart disease and Alzheimer's. It addresses the need for individualized medical care from both patient and societal perspectives, highlighting the potential to prevent suffering and improve lives. Ethical considerations such as accessibility, reliability, and the balance between biological and lifestyle factors in health are discussed. A partnership between academia and industry is essential for advancing healthcare in an economically viable way.

kelton
Télécharger la présentation

Centre for Research Ethics & Bioethics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Centre for Research Ethics & Bioethics New diagnostics – Can we afford to ignore it? An initiative by Uppsala University, The Swedish University of Agricultural Sciences and Uppsala BIO

  2. Near the patient Higher precision of diagnosis Faster test results Early phase diagnosis e.g. New markers for identifying patients at risk for heart disease, alzheimer, the actual need of antibiotics Monitoring cancer development Individalised medical care, e.g. Blood pressure

  3. Can we afford not to use it? From the patient’s perspective – early diagnosis and individualised medicine in order to prevent suffering and provide effective treatment From the perspective of society – the need to control costs (a waste of money not to individualize care), reduce sickness leave, increase quality and length of life

  4. Ethical aspects Reliability Accessibility Information Ex. The opportunity to have a whole genome scan and a life style risk profile through internet.

  5. The therapeutic gap Diagnosis yes - but what can be offered in terms of prevention or treatment? How much of the individual risk is related to biology and how much to life style?

  6. Academic & Commercial Partnership is needed between academic and commercial interests A sound relationship with IPR that promotes scientific and technical development Accessibility for patients

More Related